Baxter Names ATS CEO Andrew Hider as President, CEO

Baxter has appointed Andrew Hider as its new president and CEO, and a member of its board of directors. Hider will take office by September 3, 2025 or an earlier date pending completion of current employment contracts.

Hider has served as CEO of ATS Corporation since 2017. ATS is a provider of advanced automation solutions for companies in the life sciences, food and beverage, transportation, consumer products, and energy industries.

He was also previously president and CEO of the Taylor Made Group, a supplier of products and systems for marine, transportation, agriculture, and construction markets. Before that, he spent ten years at Danaher in various leadership position, including as president of Veeder-Root, a global supplier of automated tank gauges.

Hider began his career with GE in 2000, concluding a six-year tenure as president and general manager of GE Tri-Remanufacturing. In addition, he serves as a member of the board of Tennant Company, which designs, manufactures and sells cleaning products used primarily for non-residential surfaces.

Brent Shafer, who has served as chair and interim CEO since February 2025, will then transition to independent chair of the Baxter Board.

“Andrew is an exceptional leader with a strong track record of operational excellence, disciplined execution and innovation. We are excited that he will be Baxter’s next CEO,” said Shafer. “Andrew’s leadership at global, diversified companies underscores his ability to manage complex operations and generate value for shareholders while maintaining a focus on quality and important customer-centric missions. We are confident he is the right executive to lead Baxter into its next chapter.”

“I am energized by Baxter’s mission-driven culture and strong legacy of creating medically essential products that help address patients’ and customers’ most pressing needs,” said Andrew Hider. “Baxter has undergone a significant transformation over the last few years, refocusing the company and better positioning it for the future. I look forward to partnering with the Board and working alongside my talented future colleagues to accelerate innovation, further enhance our performance and redefine healthcare delivery while driving sustainable, long-term growth.”